Skip to main content
Top
Published in: Intensive Care Medicine 3/2011

01-03-2011 | Pediatric Original

Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children

Authors: Kiran B. Hebbar, Jana A. Stockwell, James D. Fortenberry

Published in: Intensive Care Medicine | Issue 3/2011

Login to get access

Abstract

Background

Adult studies evaluating corticosteroids have found varied efficacy. One study showing mortality benefit utilized fludrocortisone (FLU) and hydrocortisone (HC) (Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871, 2002). Use of FLU in children has not been described. We developed a protocol using HC for systemic inflammatory response syndrome (SIRS) and shock with optional addition of FLU.

Hypothesis

Addition of FLU to a HC-based steroid protocol is associated with decreased vasopressor duration without adverse effects in hypotensive children with SIRS.

Methods

Retrospective review of low-dose HC and FLU supplementation in children with SIRS and fluid refractory shock. Patients receiving FLU in addition to HC were compared with patients receiving HC alone.

Results

Ninety-seven children with SIRS and shock received steroids. Sixty of 97 (62%) received FLU in addition to HC. Seventy-three children required dopamine (DA) infusion, and 56 received norepinephrine (NE). Overall mortality was 7/97 (7%), with 5/7 (71%) nonsurvivors receiving HC + FLU. Fifty of 97 (52%) children with SIRS met definition for sepsis. Septic children who received HC + FLU required NE for significantly shorter duration than those receiving HC alone (p = 0.011). Nineteen of 60 HC + FLU patients (32%) developed nonsymptomatic hypokalemia. Hypokalemia was significantly more common in HC + FLU patients compared with those receiving HC alone (p = 0.05).

Conclusions

Overall, addition of FLU in children with SIRS was not associated with decreased vasopressor duration or vasopressor score. However, HC + FLU was associated with shorter duration of NE support in the septic subgroup. Hypokalemia was a frequent adverse finding with HC + FLU (p = 0.05). Use of FLU should be considered in further studies evaluating the role of steroids in refractory pediatric septic shock.
Literature
1.
go back to reference Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaud P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871CrossRefPubMed Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaud P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871CrossRefPubMed
2.
go back to reference Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M (1984) The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 311:1137–1143CrossRefPubMed Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M (1984) The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 311:1137–1143CrossRefPubMed
3.
go back to reference Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658CrossRefPubMed Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658CrossRefPubMed
4.
go back to reference Sjolin J (1991) High-dose corticosteroid therapy in human septic shock: has the jury reached a correct verdict? Circ Shock 35:139–151PubMed Sjolin J (1991) High-dose corticosteroid therapy in human septic shock: has the jury reached a correct verdict? Circ Shock 35:139–151PubMed
5.
go back to reference Ligtenberg JJ, Zijlstra JG (2006) Diagnosis and treatment of relative adrenal insufficiency: confusing but at a higher level? J Crit Care 21:77–78CrossRefPubMed Ligtenberg JJ, Zijlstra JG (2006) Diagnosis and treatment of relative adrenal insufficiency: confusing but at a higher level? J Crit Care 21:77–78CrossRefPubMed
6.
go back to reference Jalloul A (2005) Hydrocortisone infusion for severe community-acquired pneumonia: the role of relative adrenal insufficiency. Am J Respir Crit Care Med 172:781 (author reply 782–783) Jalloul A (2005) Hydrocortisone infusion for severe community-acquired pneumonia: the role of relative adrenal insufficiency. Am J Respir Crit Care Med 172:781 (author reply 782–783)
7.
go back to reference Nieboer P, van der Werf TS, Beentjes JA, Tulleken JE, Zijlstra JG, Ligtenberg JJ (2000) Catecholamine dependency in a polytrauma patient: relative adrenal insufficiency? Intensive Care Med 26:125–127CrossRefPubMed Nieboer P, van der Werf TS, Beentjes JA, Tulleken JE, Zijlstra JG, Ligtenberg JJ (2000) Catecholamine dependency in a polytrauma patient: relative adrenal insufficiency? Intensive Care Med 26:125–127CrossRefPubMed
8.
go back to reference Fleseriu M, Loriaux DL (2009) “Relative” adrenal insufficiency in critical illness. Endocr Pract 15:632–640CrossRefPubMed Fleseriu M, Loriaux DL (2009) “Relative” adrenal insufficiency in critical illness. Endocr Pract 15:632–640CrossRefPubMed
9.
go back to reference Ligtenberg JJ, Zijlstra JG (2004) The relative adrenal insufficiency syndrome revisited: which patients will benefit from low-dose steroids? Curr Opin Crit Care 10:456–460CrossRefPubMed Ligtenberg JJ, Zijlstra JG (2004) The relative adrenal insufficiency syndrome revisited: which patients will benefit from low-dose steroids? Curr Opin Crit Care 10:456–460CrossRefPubMed
10.
go back to reference Annetta M, Maviglia R, Proietti R, Antonelli M (2009) Use of corticosteroids in critically ill septic patients : a review of mechanisms of adrenal insufficiency in sepsis and treatment. Curr Drug Targets 10:887–894CrossRefPubMed Annetta M, Maviglia R, Proietti R, Antonelli M (2009) Use of corticosteroids in critically ill septic patients : a review of mechanisms of adrenal insufficiency in sepsis and treatment. Curr Drug Targets 10:887–894CrossRefPubMed
11.
go back to reference Karir V, Cooke CR, Andersson L, Caldwell E, Rubenfeld GD (2009) Practice variability in the assessment and treatment of critical illness-related corticosteroid insufficiency. J Crit Care Karir V, Cooke CR, Andersson L, Caldwell E, Rubenfeld GD (2009) Practice variability in the assessment and treatment of critical illness-related corticosteroid insufficiency. J Crit Care
12.
go back to reference Druce LA, Thorpe CM, Wilton A (2008) Mineralocorticoid effects due to cortisol inactivation overload explain the beneficial use of hydrocortisone in septic shock. Med Hypotheses 70:56–60CrossRefPubMed Druce LA, Thorpe CM, Wilton A (2008) Mineralocorticoid effects due to cortisol inactivation overload explain the beneficial use of hydrocortisone in septic shock. Med Hypotheses 70:56–60CrossRefPubMed
13.
go back to reference Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124CrossRefPubMed Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124CrossRefPubMed
14.
15.
go back to reference Maxime V, Lesur O, Annane D (2009) Adrenal insufficiency in septic shock. Clin Chest Med 30:17–27, vii Maxime V, Lesur O, Annane D (2009) Adrenal insufficiency in septic shock. Clin Chest Med 30:17–27, vii
16.
go back to reference Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8CrossRefPubMed Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8CrossRefPubMed
17.
go back to reference Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock:2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688CrossRefPubMed Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock:2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688CrossRefPubMed
18.
go back to reference Taketomo CK (1999) Fludrocortisone. In: Hodding JH, Kraus DM (eds) Pediatric dosage hand-book. Lexi-Comp Inc., Cleveland, p 2000 Taketomo CK (1999) Fludrocortisone. In: Hodding JH, Kraus DM (eds) Pediatric dosage hand-book. Lexi-Comp Inc., Cleveland, p 2000
19.
go back to reference Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castaneda AR, Newburger JW et al (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92:2226–2235PubMed Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castaneda AR, Newburger JW et al (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92:2226–2235PubMed
20.
go back to reference du Cheyron D, Lesage A, Daubin C, Ramakers M, Charbonneau P (2003) Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure. Intensive Care Med 29:1703–1709CrossRefPubMed du Cheyron D, Lesage A, Daubin C, Ramakers M, Charbonneau P (2003) Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure. Intensive Care Med 29:1703–1709CrossRefPubMed
21.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60CrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60CrossRefPubMed
22.
go back to reference Venkatesh B, Cohen J, Hickman I, Nisbet J, Thomas P, Ward G, Hall J, Prins J (2007) Evidence of altered cortisol metabolism in critically ill patients: a prospective study. Intensive Care Med 33:1746–1753CrossRefPubMed Venkatesh B, Cohen J, Hickman I, Nisbet J, Thomas P, Ward G, Hall J, Prins J (2007) Evidence of altered cortisol metabolism in critically ill patients: a prospective study. Intensive Care Med 33:1746–1753CrossRefPubMed
23.
go back to reference Amato MB, Carvalho CR (2006) Severe acute respiratory distress syndrome, leptospirosis, and lung protective strategies. Crit Care Med 34:2703–2704; author reply 2704CrossRefPubMed Amato MB, Carvalho CR (2006) Severe acute respiratory distress syndrome, leptospirosis, and lung protective strategies. Crit Care Med 34:2703–2704; author reply 2704CrossRefPubMed
24.
go back to reference Annane D, Cariou A, Maxime V, Azoulay E, D’Honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santre C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec’h C, Mayaud J, Lejeune J, Chevret S (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303:341–348CrossRefPubMed Annane D, Cariou A, Maxime V, Azoulay E, D’Honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santre C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec’h C, Mayaud J, Lejeune J, Chevret S (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303:341–348CrossRefPubMed
25.
go back to reference (2009) Abstracts of the Society of Critical Care Medicine’s 39th Critical Care Congress. January 9–13, 2010. Miami Beach, Florida, USA. Crit Care Med 37: A1–A542 (2009) Abstracts of the Society of Critical Care Medicine’s 39th Critical Care Congress. January 9–13, 2010. Miami Beach, Florida, USA. Crit Care Med 37: A1–A542
26.
go back to reference Ceneviva G, Paschall JA, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:e19CrossRefPubMed Ceneviva G, Paschall JA, Maffei F, Carcillo JA (1998) Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:e19CrossRefPubMed
27.
go back to reference Trimarchi T (2006) Endocrine problems in critically ill children: an overview. AACN Clin Issues 17:66–78CrossRefPubMed Trimarchi T (2006) Endocrine problems in critically ill children: an overview. AACN Clin Issues 17:66–78CrossRefPubMed
28.
go back to reference Carcillo JA, Fields AI (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30:1365–1378CrossRefPubMed Carcillo JA, Fields AI (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30:1365–1378CrossRefPubMed
29.
go back to reference Carcillo JA, Fields AI (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. J Pediatr (Rio J) 78:449–466CrossRef Carcillo JA, Fields AI (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. J Pediatr (Rio J) 78:449–466CrossRef
Metadata
Title
Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children
Authors
Kiran B. Hebbar
Jana A. Stockwell
James D. Fortenberry
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 3/2011
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-010-2090-3

Other articles of this Issue 3/2011

Intensive Care Medicine 3/2011 Go to the issue